Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-β-D-arabinofuranosyl-5-iodocytosine Journal Article


Authors: Colacino, J.; Brownridge, E.; Greenberg, N.; Lopez, C.
Article Title: Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-β-D-arabinofuranosyl-5-iodocytosine
Abstract: The deoxypyrimidine nucleoside analog 2-fluoro-2'-deoxy-1-β-D-arabinofuranosyl-5-iodocytosine (FIAC) is a potent and selective inhibitor of herpes simplex virus type 1 in vitro. Isopycnographic analysis demonstrated that 1 μM FIAC inhibited herpes simplex virus DNA replication by more than 95% but inhibited cellular DNA replication by only 32%. Mutant herpes simplex virus type 1 selected resistant to FIAC displayed linked resistance to other nucleoside analogs, including arabinosylthymine and acyclovir. Lysates derived from Vero cells infected with FIAC-resistant virus showed markedly lower levels of thymidine kinase activity and were unable to phosphorylate selectively arabinosylthymine or FIAC, in contrast to lysates from cells infected with wild-type herpes simplex virus type 1. Finally, drug-resistant virus displayed a 6,000-fold decrease in pathogenicity when inoculated intraperitoneally into genetically susceptible A/J mice. These results indicate that resistance to deoxypyrimidine nucleoside analogs is due, at least in part, to alterations in viral thymidine kinase and is accompanied by decreased pathogenicity in vivo.
Keywords: unclassified drug; nonhuman; mouse; animal model; aciclovir; in vitro study; drug resistance; enzymology; cell culture; thymidine kinase; antivirus agent; virus infection; pathogenicity; radioisotope; herpes simplex virus 1; thymidine h 3; phosphonoacetic acid; virus mutation; experimental infection; intraperitoneal drug administration; 5 (2 bromovinyl) 2' deoxyuridine; clevudine; fiacitabine; priority journal; article; 2' fluoro 5 iodocytarabine c 14; thymine arabinoside
Journal Title: Antimicrobial Agents and Chemotherapy
Volume: 29
Issue: 5
ISSN: 0066-4804
Publisher: American Society for Microbiology  
Date Published: 1986-05-01
Start Page: 877
End Page: 882
Language: English
DOI: 10.1128/aac.29.5.877
PUBMED: 3015008
PROVIDER: scopus
PMCID: PMC284171
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics